New Publication in Communications Medicine
Published:
We are delighted to announce the publication of research article Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction in Communications Medicine. The study was led by collaborators at the University of Sheffield and Sheffield Teaching Hospitals, with members of the Sheffield Cancer Bioinformatics Group contributing to the computational analysis and interpretation of the data.
The study demonstrates how ex vivo drug screening of freshly resected bladder tumours can be used to identify patient-specific drug sensitivities and resistance profiles within a clinically relevant timeframe. By screening tumour samples against a panel of standard-of-care and emerging therapies, the research identified distinct tumour subgroups with differing treatment responses, highlighting the potential of functional precision medicine to guide personalised treatment decisions.
Our contribution focused on processing of the raw whole genome sequencing data and the bioinformatics analyses used to explore relationships between drug response, tumour characteristics, and molecular features. Integrating these data enabled the identification of clinically meaningful patterns that could help predict treatment response and support future patient stratification strategies.
This work represents an important step towards more personalised treatment for bladder cancer and demonstrates the value of combining laboratory experimentation with computational analysis to advance precision oncology. We look forward to building on these findings through continued collaboration with our clinical and translational research partners.
